Observational study of the effectiveness of Korean seed tea for dementia

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1031250077

Enrollment

Registered

2025-05-01

Start date

2025-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia Dementia

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: A case report of Korean seed tea being used in dementia patients for whom standard medications were not working.

Exclusion criteria

Exclusion criteria: 1) Patients who were unable to continue the study due to hypersensitivity or allergic reactions to Korean seed tea. 2) Patients who are taking other drugs concomitantly, or who have previously participated in clinical trials and have not yet taken the test drug for more than one month. 3) Patients who are otherwise deemed inappropriate by the principal investigator or co-investigator.

Design outcomes

Primary

Measure	Time frame
Efficacy was evaluated based on the degree of improvement in the main complaint, with reference to the Hasegawa Dementia Scale, MMSE (Mini-Mental State Examination), etc.	—

Secondary

Measure	Time frame
Adverse event rates were measured using CTCAE	—

Contacts

Public ContactHideo Kobayashi

Japan Society of Clinical Study for Frontier-Medicine

cro@jscsf.net+81-355421597

Outcome results